CNTA NASDAQ
Centessa Pharmaceuticals plc
1W: +0.8%
1M: +1.7%
3M: +41.1%
YTD: +71.0%
1Y: +210.6%
3Y: +537.8%
5Y: +63.6%
$40.50
Last traded 2026-06-29 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Balance Sheet Trends
Total Assets
$577M
+60.1% ▲
4Y CAGR: +164.9%
Total Liabilities
$175M
+41.3% ▲
4Y CAGR: +112.3%
Shareholders Equity
$402M
+70.0% ▲
4Y CAGR: +237.4%
Cash & Investments
$482M
+87.9% ▲
4Y CAGR: +185.8%
Total Debt
$117M
+38.6% ▲
4Y CAGR: +113.6%
Net Debt
-$266M
-512.3% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $7M | $595M | $394M | $128M | $383M |
| Short-Term Investments | $0 | $0 | $0 | $129M | $99M |
| Cash & ST Investments | $7M | $595M | $394M | $257M | $482M |
| Net Receivables | $0 | $17M | $27M | $39M | $45M |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $4M | $993K | $3M | $2M | $2M |
| Total Current Assets | $11M | $629M | $438M | $315M | $536M |
| Property, Plant & Equip. | $0 | $162K | $1M | $13M | $12M |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $552K | $699K | $2M | $3M | $2M |
| Total Non-Current Assets | $552K | $861K | $7M | $45M | $40M |
| Total Assets | $12M | $630M | $444M | $360M | $577M |
| — Liabilities — | |||||
| Accounts Payable | $1M | $8M | $14M | $12M | $7M |
| Short-Term Debt | $6M | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $922K | $5M | $8M | $839K | $10M |
| Total Current Liabilities | $9M | $25M | $38M | $39M | $58M |
| Long-Term Debt | $0 | $76M | $70M | $76M | $109M |
| Other Non-Current Liab. | $0 | $38M | $0 | $29K | $29K |
| Total Non-Current Liabilities | $0 | $113M | $70M | $85M | $117M |
| Total Liabilities | $9M | $138M | $108M | $124M | $175M |
| — Equity — | |||||
| Common Stock | $26M | $252K | $265K | $273K | $359K |
| Retained Earnings | -$24M | -$386M | -$602M | -$753M | -$989M |
| Accumulated OCI | $572K | $688K | -$1M | $1M | $4M |
| Total Stockholders Equity | $3M | $492M | $336M | $236M | $402M |
| Total Liabilities & Equity | $12M | $630M | $444M | $360M | $577M |
| — Key Metrics — | |||||
| Total Debt | $6M | $76M | $70M | $85M | $117M |
| Net Debt | -$2M | -$519M | -$324M | -$43M | -$266M |
| Total Investments | $0 | $0 | $0 | $129M | $99M |